Literature DB >> 25341944

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Fabiana Rached1, Raul D Santos2, Laurent Camont3, Marcio H Miname2, Marie Lhomme3, Carolane Dauteuille3, Sora Lecocq3, Carlos V Serrano2, M John Chapman3, Anatol Kontush3.   

Abstract

To evaluate functional and compositional properties of HDL in subjects from a kindred of genetic apoA-I deficiency, two homozygotes and six heterozygotes, with a nonsense mutation at APOA1 codon -2, Q[-2]X, were recruited together with age- and sex-matched healthy controls (n = 11). Homozygotes displayed undetectable plasma levels of apoA-I and reduced levels of HDL-cholesterol (HDL-C) and apoC-III (5.4% and 42.6% of controls, respectively). Heterozygotes displayed low HDL-C (21 ± 9 mg/dl), low apoA-I (79 ± 24 mg/dl), normal LDL-cholesterol (132 ± 25 mg/dl), and elevated TG (130 ± 45 mg/dl) levels. Cholesterol efflux capacity of ultracentrifugally isolated HDL subpopulations was reduced (up to -25%, P < 0.01, on a glycerophospholipid [GP] basis) in heterozygotes versus controls. Small, dense HDL3 and total HDL from heterozygotes exhibited diminished antioxidative activity (up to -48%, P < 0.001 on a total mass basis) versus controls. HDL subpopulations from both homozygotes and heterozygotes displayed altered chemical composition, with depletion in apoA-I, GP, and cholesteryl ester; enrichment in apoA-II, free cholesterol, and TG; and altered phosphosphingolipidome. The defective atheroprotective activities of HDL were correlated with altered lipid and apo composition. These data reveal that atheroprotective activities of HDL particles are impaired in homozygous and heterozygous apoA-I deficiency and are intimately related to marked alterations in protein and lipid composition.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HDL functionality; antioxidative activity; apolipoprotein A-I; cellular cholesterol efflux; familial deficiency; genetics; high density lipoprotein; lipidomics

Mesh:

Substances:

Year:  2014        PMID: 25341944      PMCID: PMC4242444          DOI: 10.1194/jlr.M051631

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

1.  Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

Authors:  Laurent Camont; Marie Lhomme; Fabiana Rached; Wilfried Le Goff; Anne Nègre-Salvayre; Robert Salvayre; Catherine Calzada; Michel Lagarde; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

2.  Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system.

Authors:  N Fournier; V Atger; A Cogny; B Vedie; P Giral; A Simon; N Moatti; J L Paul
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

Review 3.  The effects of altered apolipoprotein A-I structure on plasma HDL concentration.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

4.  A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.

Authors:  M J Chapman; S Goldstein; D Lagrange; P M Laplaud
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

5.  Phospholipid identification and quantification of membrane vesicle subfractions by 31P-1H two-dimensional nuclear magnetic resonance.

Authors:  B Larijani; D L Poccia; L C Dickinson
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

6.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

Authors:  Boris Hansel; Philippe Giral; Estelle Nobecourt; Sandrine Chantepie; Eric Bruckert; M John Chapman; Anatol Kontush
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

7.  Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.

Authors:  Maryse Guerin; Pascal Egger; Céline Soudant; Wilfried Le Goff; Arie van Tol; Reynald Dupuis; M John Chapman
Journal:  Atherosclerosis       Date:  2002-08       Impact factor: 5.162

8.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Authors:  D S Ng; L A Leiter; C Vezina; P W Connelly; R A Hegele
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

9.  Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

Authors:  Anatol Kontush; Sandrine Chantepie; M John Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

10.  Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent.

Authors:  Sandra Larrede; Carmel M Quinn; Wendy Jessup; Eric Frisdal; Maryline Olivier; Victar Hsieh; Mi-Jurng Kim; Miranda Van Eck; Philippe Couvert; Alain Carrie; Philippe Giral; M John Chapman; Maryse Guerin; Wilfried Le Goff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-03       Impact factor: 8.311

View more
  8 in total

1.  The effects of apolipoprotein B depletion on HDL subspecies composition and function.

Authors:  W Sean Davidson; Anna Heink; Hannah Sexmith; John T Melchior; Scott M Gordon; Zsuzsanna Kuklenyik; Laura Woollett; John R Barr; Jeffrey I Jones; Christopher A Toth; Amy S Shah
Journal:  J Lipid Res       Date:  2016-02-23       Impact factor: 5.922

2.  The Correlation of Total Percent Fat With Alterations in Cholesterol and Triglycerides in Adults.

Authors:  Juan Sun; Zimu Zhang; Zhen Liu; Jie Li; Weiming Kang
Journal:  Front Nutr       Date:  2022-05-31

3.  Mechanism of Phospholipid Hydrolysis for Oyster Crassostrea plicatula Phospholipids During Storage Using Shotgun Lipidomics.

Authors:  Qinsheng Chen; Xincen Wang; Peixu Cong; Yanjun Liu; Yuming Wang; Jie Xu; Changhu Xue
Journal:  Lipids       Date:  2017-10-03       Impact factor: 1.880

4.  Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study).

Authors:  Anna Pedret; Úrsula Catalán; Sara Fernández-Castillejo; Marta Farràs; Rosa-M Valls; Laura Rubió; Núria Canela; Gerard Aragonés; Marta Romeu; Olga Castañer; Rafael de la Torre; Maria-Isabel Covas; Montse Fitó; Maria-José Motilva; Rosa Solà
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

5.  Metabolomics Profiling of Vitamin D Status in Relation to Dyslipidemia.

Authors:  Hanaa Mousa; Mohamed A Elrayess; Ilhame Diboun; Simon K Jackson; Susu M Zughaier
Journal:  Metabolites       Date:  2022-08-22

Review 6.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25

7.  Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects: A Lipidomic Analysis of the VOHF Study.

Authors:  Sara Fernández-Castillejo; Anna Pedret; Úrsula Catalán; Rosa-Maria Valls; Marta Farràs; Laura Rubió; Olga Castañer; Alba Macià; Montse Fitó; Maria José Motilva; Maria-Isabel Covas; Martin Giera; Alan T Remaley; Rosa Solà
Journal:  Mol Nutr Food Res       Date:  2021-03-18       Impact factor: 6.575

8.  Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.

Authors:  Fumiaki Furuyama; Shinji Koba; Yuya Yokota; Fumiyoshi Tsunoda; Makoto Shoji; Youichi Kobayashi
Journal:  J Atheroscler Thromb       Date:  2017-08-30       Impact factor: 4.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.